Elkfork Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $457K | Buy |
8,738
+680
| +8% | +$35.6K | 0.01% | 607 |
|
|
2019
Q2 | $389K | Buy |
8,058
+102
| +1% | +$4.92K | 0.01% | 652 |
|
|
2019
Q1 | $402K | Hold |
7,956
| – | – | 0.01% | 618 |
|
|
2018
Q4 | $472K | Buy |
7,956
+34
| +0.4% | +$2.02K | 0.01% | 532 |
|
|
2018
Q3 | $521K | Buy |
7,922
+34
| +0.4% | +$2.24K | 0.01% | 582 |
|
|
2018
Q2 | $398K | Hold |
7,888
| – | – | 0.01% | 600 |
|
|
2018
Q1 | $415K | Buy |
7,888
+986
| +14% | +$51.9K | 0.01% | 584 |
|
|
2017
Q4 | $321K | Buy |
6,902
+1,190
| +21% | +$55.3K | 0.01% | 660 |
|
|
2017
Q3 | $231K | Buy |
5,712
+1,598
| +39% | +$64.6K | 0.01% | 694 |
|
|
2017
Q2 | $139K | Buy |
4,114
+2,074
| +102% | +$70.1K | ﹤0.01% | 784 |
|
|
2017
Q1 | $59K | Sell |
2,040
-1,972
| -49% | -$57K | ﹤0.01% | 864 |
|
|
2016
Q4 | $132K | Buy |
+4,012
| New | +$132K | ﹤0.01% | 671 |
|